Virbac : Déclaration d'actions et de droits de vote 01/2026 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577 DATENombre total d’actions composant le capital socialNombre total de droits de vote31 janvier 20268 390 660Total brut de droits de vote : 12 704 131Total net* de droits de vote : 12 691 295 Total net* = nombre total de droits de vote attachés au ...
Virbac : Declaration of the number of shares and voting rights 01/2026 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJanuary, 31 20268 390 660Gross total of voting rights : 12 704 131Net total* of voting rights : 12 691...
Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries Full-year 2025 revenue reached €1,465m : +7.9% at constant exchange rate and scope (CERS) vs 2024+4.8% at actual rates impacted by significant currency headwinds, particularly in Latin America, IMEA and the Pacific. Strong companion animal growth of +10.9% and farm animal of +6.1% at CERS Solid volume/mix effect of ~+5%, completed by price increase of ~+3%Excellent performance in 2025 in the USA (+14.7% at CERS), followed by IMEA (+9.5%), Latin America (+7.5%) and Euro...
Virbac: solide croissance en 2025 avec un chiffre d'affaires annuel en hausse de +7,9 % à pcc3, forte dynamique dans les catégories et pays clés Le chiffre d'affaires annuel 2025 atteint 1 465 M€ +7,9 % à taux de change et périmètre constants (pcc) comparé à 2024+4,8 % à taux réels, impactés par des effets de change très défavorables, notamment en Amérique latine, dans la zone IMEA et dans le Pacifique. Forte croissance des animaux de compagnie (+10,9 %) et des animaux d'élevage (+6,1 %).Solide effet volume/mix d'environ +5 %, complété par une hausse des prix d'environ +3 %.Excellen...
A director at Abivax sold 1,000,000 shares at 122.334USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.